APP and Alzheimer disease: AD mice on a HFD had poorer memory, increased brain Aβ neuropathology with higher levels of Aβ40/42 in the hippocampus, an increased Aβ production in the cortex (more APP γ-C-terminal fragments and plaque burden), and lower levels of IDE [169].